Novel Transdermal Nanoparticles for Melanoma Treatment
- Detailed Technology Description
- None
- Supplementary Information
- Inventor: Mohapatra, Shyam S. | Sahoo, Bishwabhusan | Kumar, Arun | Behera, Sumita
Priority Number: US7371738B2
IPC Current: A01N004304
US Class: 514054 | 42400934 | 424489 | 424499 | 424501 | 424646 | 536053 | 536123 | 977788 | 977797 | 977798 | 977801 | 977930
Assignee Applicant: University of South Florida,Tampa
Title: Method of transdermal drug delivery using hyaluronic acid nanoparticles
Usefulness: Method of transdermal drug delivery using hyaluronic acid nanoparticles
Summary: The method is useful for preparing hyaluronic acid nanoparticles (claimed). The particles are useful for transdermal drug delivery.
- Industry
- Biomedical
- Sub Category
- Medical Device
- *Abstract
-
A new method of transdermal drug delivery using hyaluronic acid (HA) nanoparticleshas been developed by researchers at the University of South Florida. Nanoparticles of HA can be formulated to encapsulate peptides, DNA and small drug molecules, thus making an attractive candidate for cell specific drug delivery.
- Country/Region
- USA
For more information, please click Here

